Search results
IARC Monograph on Glyphosate Q&A on Glyphosate. DOWNLOAD PDF. In March 2015, IARC classified glyphosate as “probably carcinogenic to humans” (Group 2A). This was based on “limited” evidence of cancer in humans (from real-world exposures that actually occurred) and “sufficient” evidence of cancer in experimental animals (from studies ...
Jun 30, 2023 · But what does it all mean? Aspartame: What else is 'possibly carcinogenic'? Aspartame is expected to join aloe vera and bracken ferns on the WHO's list as a "possible human carcinogen".
Jul 1, 2011 · The authors quote correctly that the ‘International Agency for Research on Cancer (IARC) classified styrene as possibly carcinogenic to humans (Group 2B) and SO as probably carcinogenic to humans (Group 2A)’. IARC’s evaluation of the available human studies nearly 10 years ago stated ‘There is limited evidence in humans for the ...
Feb 24, 2015 · The IARC Monographs on the Evaluation of Carcinogenic Risks to Humans of the International Agency for Research on Cancer (IARC) are a prominent example of such an expert review process. The goal of the Monograph Programme is to assess carcinogenic hazards from occupational, environmental, and lifestyle exposures and agents, thus providing an ...
Nov 14, 2023 · A Working Group of 30 international experts from 11 countries was convened by the IARC Monographs programme for a meeting on 7–14 November 2023 in Lyon. After thoroughly reviewing the extensive published literature, the Working Group classified PFOA as carcinogenic to humans (Group 1) and PFOS as possibly carcinogenic to humans (Group 2B).
Grade 1: Cancer-causing substances with evidence supporting carcinogenicity in humans. Eg: asbestos, processed meats, smoking; Grade 2: Substances that are probably carcinogenic to humans. 2A: Grade 2 substances with sufficient evidence of carcinogenicity in animals and limited evidence in humans. This includes DDT, red meat, working night ...
The categorization is a matter of scientific judgement that reflects the strength of evidence derived from studies in humans, experimental animals and other relevant data. The classification is based only on the strength of evidence for carcinogenicity, not on the relative increase of cancer risk due to exposure, or on the amount of agent ...
